{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal AdMSC",
            "NStudiesAvail": 430108,
            "NStudiesFound": 57,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 57,
            "FieldList": [
                  "MaximumAge",
                  "MinimumAge",
                  "NCTId",
                  "NCTIdAlias",
                  "OfficialTitle",
                  "OrgClass",
                  "OrgFullName",
                  "OrgStudyId",
                  "OrgStudyIdDomain",
                  "OrgStudyIdLink",
                  "OrgStudyIdType",
                  "OtherEventAssessmentType",
                  "OtherEventNotes",
                  "OtherEventOrganSystem",
                  "OtherEventSourceVocabulary"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03265613"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2017-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 2,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03392311"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2016-04-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 3,
                        "MaximumAge": [
                              "85 Years"
                        ],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT04228666"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBALZ01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 4,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT05329662"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Efficacy for the Treatment of Sexual Function Impairment in Female"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Vinmec Research Institute of Stem Cell and Gene Technology"
                        ],
                        "OrgStudyId": [
                              "ISC.21.73"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 5,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "15 Years"
                        ],
                        "NCTId": [
                              "NCT04654286"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Outcomes of Human Amniotic Membrane and Allogeneic Mesenchymal Stem Cells Composite Augmentation for Nerve Transfer Procedure in Brachial Plexus Injury Patients"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Dr. Soetomo General Hospital"
                        ],
                        "OrgStudyId": [
                              "647 / Panke.KKE/ XI / 2016"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 6,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04312113"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Single Site Open Label Study of Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "19-000826"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 7,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "35 Years"
                        ],
                        "NCTId": [
                              "NCT03346967"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Vinmec Research Institute of Stem Cell and Gene Technology"
                        ],
                        "OrgStudyId": [
                              "VinmecRISCGT72"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 8,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04785027"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis: a Pilot Study for a Randomized Controlled Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2020-01-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 9,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04349631"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase II, Open Label, Single-Center, Clinical Trial to Assess Efficacy of HB-adMSCs to Provide Immune Support Against Coronavirus Disease"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCOV01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 10,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03691909"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1/2a Clinical Trial to Assess Safety of a Single IV Infusion of Autologous Adipose-derived Mesenchymal Stem Cells in Adults With Active Rheumatoid Arthritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBRA01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [
                              "Rheumatoid Arthritis Flare/Worsening of RA",
                              "Staph Infection",
                              "Diffuse Rash/Rash on Abdomen",
                              "Shortness of Breath",
                              "Bowel Blockage",
                              "Anemia/Anemia Chronic Disease",
                              "Renal Insufficiency",
                              "Right Eyelid Pruritis",
                              "Cyst Right Ear",
                              "Neck Spasm"
                        ],
                        "OtherEventOrganSystem": [
                              "Immune system disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Respiratory, thoracic and mediastinal disorders",
                              "Gastrointestinal disorders",
                              "Blood and lymphatic system disorders",
                              "Vascular disorders",
                              "Blood and lymphatic system disorders",
                              "Infections and infestations",
                              "Renal and urinary disorders",
                              "Eye disorders",
                              "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                              "Musculoskeletal and connective tissue disorders",
                              "Infections and infestations",
                              "Surgical and medical procedures"
                        ],
                        "OtherEventSourceVocabulary": [
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT",
                              "SNOMED CT"
                        ]
                  },
                  {
                        "Rank": 11,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04087889"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND of Hope Biosciences Allogeneic First Blood Relative Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPC01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 12,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04275024"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Guangdong Provincial Hospital of Traditional Chinese Medicine"
                        ],
                        "OrgStudyId": [
                              "S2016-05-02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 13,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04289194"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase 1/2 Clinical Study to Assess the Feasibility, Safety, Tolerability and Preliminary Efficacy of the Administration of HCR040, Allogeneic Adipose-derived Adult Mesenchymal Stem Cells, in Acute Respiratory Distress Syndrome"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Histocell, S.L."
                        ],
                        "OrgStudyId": [
                              "ALICELL-CT-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 14,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02801890"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Autologous AD-MSC Transplantation in Peritoneal Dialysis Patients With Ultra Filtration Failure and Evaluation of Cellular and Molecular Effects of Mesenchymal Stem Cell Infusion on Peritoneal Fibrosis"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-kidney-006"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 15,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT03869229"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Effectiveness of Adipose-derived Mesenchymal Stem Cells in Patients With Osteoarthritis of the Knee, Hip or Glenohumeral Joint and Analysis of the Regeneration Processes Based on Inflammatory Markers, microRNAs and Clinical Features."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Medical University of Warsaw"
                        ],
                        "OrgStudyId": [
                              "002/LIFE/2019"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 16,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "19 Years"
                        ],
                        "NCTId": [
                              "NCT04527224"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I/\u2161a Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 Pneumonia"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Nature Cell Co. Ltd."
                        ],
                        "OrgStudyId": [
                              "ASVP1N2A-US"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 17,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "40 Years"
                        ],
                        "NCTId": [
                              "NCT02107118"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "H-34570: PHASE I Study: The Use of Autologous Adipose Tissue-Derived Mesenchymal Stem Cell (AdMSC) for the Improvement of Erectile and Cardiac Function in Aging Men"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Baylor College of Medicine"
                        ],
                        "OrgStudyId": [
                              "H-34570 No.11-13-40-07"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 18,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04348435"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCOV02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 19,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "14 Years"
                        ],
                        "NCTId": [
                              "NCT02407470"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Navy General Hospital, Beijing"
                        ],
                        "OrgStudyId": [
                              "Ginkgocell-ADHSC-AA-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 20,
                        "MaximumAge": [
                              "55 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04063215"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBTBI01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 21,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "5 Years"
                        ],
                        "NCTId": [
                              "NCT05308836"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Vinmec Research Institute of Stem Cell and Gene Technology"
                        ],
                        "OrgStudyId": [
                              "ISC20.01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 22,
                        "MaximumAge": [
                              "14 Years"
                        ],
                        "MinimumAge": [
                              "2 Years"
                        ],
                        "NCTId": [
                              "NCT02382874"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Allogenic Adipose Derived Mesenchymal Stromal Cells Transplantation to Improve Kidney Function in Refractory Primary Nephrotic Syndrome (Focal Segmental Glomerulosclerosis,FSGS) ,a Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Kidney-005"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 23,
                        "MaximumAge": [
                              "12 Months"
                        ],
                        "MinimumAge": [
                              "2 Months"
                        ],
                        "NCTId": [
                              "NCT04889963"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome)"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Gadjah Mada University"
                        ],
                        "OrgStudyId": [
                              "STEMCELL-LIGAMENTREGENERATION"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 24,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04362189"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCOV03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 25,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03925649"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND (Investigational New Drug) of Autologous HB-adMSCs for the Treatment of Spinal Cord Injury"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBSCI01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 26,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "3 Years"
                        ],
                        "NCTId": [
                              "NCT04029896"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND of Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCP01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 27,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04368806"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee Osteoarthritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Nature Cell Co. Ltd."
                        ],
                        "OrgStudyId": [
                              "JS-OAP3-US01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 28,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04428801"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study for the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus 2019 (COVID-19)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Celltex Therapeutics Corporation"
                        ],
                        "OrgStudyId": [
                              "CTX0020-003"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 29,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT03000712"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "R-Bio"
                        ],
                        "OrgStudyId": [
                              "HTO-MSCs"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 30,
                        "MaximumAge": [
                              "80 Years"
                        ],
                        "MinimumAge": [
                              "45 Years"
                        ],
                        "NCTId": [
                              "NCT04995081"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's Disease"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPD04"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 31,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05116540"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-Blind, Single-Center, Phase 2, Efficacy and Safety Study of Autologous HB-adMSCs vs Placebo for the Treatment of Patients With Multiple Sclerosis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBMS01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 32,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "19 Years"
                        ],
                        "NCTId": [
                              "NCT01643681"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "R-Bio"
                        ],
                        "OrgStudyId": [
                              "KSC-MSCs-LIDD"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 33,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04604288"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND to Evaluate the Safety and Preliminary Efficacy of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBKP01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 34,
                        "MaximumAge": [
                              "50 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02208713"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intramuscular Transplantation of Autologous Muscle Derived Stem Cell(MDSC) and Adipose Derived Mesenchymal Stem Cells (AD-MSC) in Patients With Facioscapulohumeral Dystrophy (FSHD), Phase I Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Royan-Nerve-007"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 35,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04064957"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBSCI02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 36,
                        "MaximumAge": [
                              "39 Years"
                        ],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT02603744"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Evaluate the Safety and Feasibility of Intra-ovarian Injection of Autologous Adipose Derived Mesenchymal Stromal Cells (ADMSC) in Women With Premature Ovarian Failure(POF)"
                        ],
                        "OrgClass": [
                              "OTHER_GOV"
                        ],
                        "OrgFullName": [
                              "Royan Institute"
                        ],
                        "OrgStudyId": [
                              "Rep-Bio-Royan-001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 37,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04928287"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "\"A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Autologous HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's Disease\""
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPD03"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 38,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03461458"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase I Study Evaluating the Safety and Feasibility of Autologous, Culture-Expanded Adipose-Derived Mesenchymal Stromal Cells in Subjects With Painful Degenerative Disc Disease"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-002136"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 39,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05017298"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study for Subjects With Coronavirus 2019 (COVID-19) Using Multiple Dose Intravenous Infusions of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Celltex Therapeutics Corporation"
                        ],
                        "OrgStudyId": [
                              "CTX0020-004"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 40,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "20 Years"
                        ],
                        "NCTId": [
                              "NCT03254758"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1/2 Study of ADR-001 in Patients With Liver Cirrhosis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Rohto Pharmaceutical Co., Ltd."
                        ],
                        "OrgStudyId": [
                              "ADR-001-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 41,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04351932"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Universidad Catolica Santiago de Guayaquil"
                        ],
                        "OrgStudyId": [
                              "UCSantiagodeGuayaquil001"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 42,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05126563"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Randomized, Double-blinded, Single-center, Phase 2 Efficacy, and Safety Study of Allogeneic HB-adMSCs for the Treatment of Patients With Chronic Post-COVID-19 Syndrome."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPCOVID02"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 43,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT03308565"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "17-004621"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 44,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04711811"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND Using HB-adMSCs for the Treatment of Chronic Musculoskeletal Pain."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCMP01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 45,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04514952"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBALS01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 46,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT02338271"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Safety and Efficacy Study of Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Bundang CHA Hospital"
                        ],
                        "OrgStudyId": [
                              "ADMSC-DD-Han"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 47,
                        "MaximumAge": [
                              "95 Years"
                        ],
                        "MinimumAge": [
                              "76 Years"
                        ],
                        "NCTId": [
                              "NCT04772378"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Intermediate Size Patient Population Expanded Access IND to Evaluate the Safety of Autologous HB-adMSCs for the Treatment of Patients With Parkinson's Disease."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPD05"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 48,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04520373"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "CELLTOP Part II: A Phase II Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury"
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Mayo Clinic"
                        ],
                        "OrgStudyId": [
                              "19-011706"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 49,
                        "MaximumAge": [
                              "70 Years"
                        ],
                        "MinimumAge": [
                              "30 Years"
                        ],
                        "NCTId": [
                              "NCT02135380"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intravenous Autologous Adipose Derived Adult Stem Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF)."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Kasiak Research Pvt. Ltd."
                        ],
                        "OrgStudyId": [
                              "KRPL/IPF/11-12/002"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 50,
                        "MaximumAge": [
                              "65 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04798066"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Patients With Post-COVID-19 Syndrome."
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPCOV01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 51,
                        "MaximumAge": [
                              "75 Years"
                        ],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT05521672"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Trial Phase IIa to Evaluate the Safety and Effectiveness of Treatment With Fat-derived Mesenchymal Allogenic Mesenchymal Troncal Cells in Patients With Single Inflammatory Stenosis in the Context of Crohn's Disease."
                        ],
                        "OrgClass": [
                              "OTHER"
                        ],
                        "OrgFullName": [
                              "Instituto de Investigaci\u00f3n Sanitaria de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz"
                        ],
                        "OrgStudyId": [
                              "FJD-MEIC-21-01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 52,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04448106"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "Clinical Study for Subjects With Osteoarthritis of Knees, Hips, and Shoulders Using a Combination of Intravenous Infusions With Intra-articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Celltex Therapeutics Corporation"
                        ],
                        "OrgStudyId": [
                              "CTX0020-002"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 53,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04825626"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Expanded Access IND to Evaluate the Safety and Preliminary Efficacy of Autologous HB-adMSCs for the Treatment of a Single Patient With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBCIDP01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 54,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "18 Years"
                        ],
                        "NCTId": [
                              "NCT04825613"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "\"Individual Patient Expanded Access IND to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Primary Lateral Sclerosis\""
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPLS01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 55,
                        "MaximumAge": [],
                        "MinimumAge": [],
                        "NCTId": [
                              "NCT04064983"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "An Expanded Access IND to Evaluate the Safety and Efficacy of Autologous HB-adMSCs for the Treatment of a Single Patient With Polyneuropathy"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Hope Biosciences"
                        ],
                        "OrgStudyId": [
                              "HBPN01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [],
                        "OtherEventSourceVocabulary": []
                  },
                  {
                        "Rank": 56,
                        "MaximumAge": [
                              "60 Years"
                        ],
                        "MinimumAge": [
                              "22 Years"
                        ],
                        "NCTId": [
                              "NCT02674399"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 2, Double-Blind, Randomized, Controlled Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Treatment of Osteoarthritis"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Nature Cell Co. Ltd."
                        ],
                        "OrgStudyId": [
                              "JS-OAP2-US01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "Musculoskeletal and connective tissue disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Infections and infestations",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Injury, poisoning and procedural complications",
                              "Gastrointestinal disorders",
                              "Nervous system disorders",
                              "Respiratory, thoracic and mediastinal disorders"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1"
                        ]
                  },
                  {
                        "Rank": 57,
                        "MaximumAge": [],
                        "MinimumAge": [
                              "50 Years"
                        ],
                        "NCTId": [
                              "NCT03117738"
                        ],
                        "NCTIdAlias": [],
                        "OfficialTitle": [
                              "A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's Disease"
                        ],
                        "OrgClass": [
                              "INDUSTRY"
                        ],
                        "OrgFullName": [
                              "Nature Cell Co. Ltd."
                        ],
                        "OrgStudyId": [
                              "AST-ADP2-US01"
                        ],
                        "OrgStudyIdDomain": [],
                        "OrgStudyIdLink": [],
                        "OrgStudyIdType": [],
                        "OtherEventAssessmentType": [
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment",
                              "Systematic Assessment"
                        ],
                        "OtherEventNotes": [],
                        "OtherEventOrganSystem": [
                              "Eye disorders",
                              "Gastrointestinal disorders",
                              "Gastrointestinal disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "General disorders",
                              "Injury, poisoning and procedural complications",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Metabolism and nutrition disorders",
                              "Nervous system disorders",
                              "Psychiatric disorders",
                              "Skin and subcutaneous tissue disorders",
                              "Infections and infestations",
                              "Infections and infestations"
                        ],
                        "OtherEventSourceVocabulary": [
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1",
                              "MedDRA 18.1"
                        ]
                  }
            ]
      }
}